Literature DB >> 11127751

Detection of false negative Pap smears by rapid reviewing. A metaanalysis.

M Arbyn1, U Schenck.   

Abstract

OBJECTIVE: To explore the diagnostic validity of rapid reviewing (RR) as a quality control method in cytologic laboratories. STUDY
DESIGN: Fourteen studies dealing with the detection of false negative Pap smears by RR were included in a metaanalysis.
RESULTS: The overall additional yield of positive slides, expressed as the percentage of all reviewed slides, is: 0.18% (95% confidence interval [CI]: .14-.21) for all cytologic abnormalities; 0.07% (CI: .05-.09) for squamous intraepithelial lesions (SIL) and 0.02% (CI: .01-.03) for high grade SIL. The false negative rate of primary screening, evaluated by RR, was 2.0% (CI: 1.5-2.6) for all cytologic abnormalities and 1.4% (CI: .8-2.1) for high grade SIL. The specificity of rapid rescreening was estimated as 97.2% (CI: 96.4-98.1). The positive predictive value of suspicion at RR is about 8.8%. Seven references contained historical data on full rescreening of a random sample of slides reported originally as negative. The results were also pooled and compared with RR. Complete rescreening is more sensitive, but if applied on only 10% of the negative workload, it would yield, on average, 4.7 times fewer extra positives, 5.6 times fewer SIL and 7.9 times fewer high grade SIL in comparison with RR of all sides.
CONCLUSION: RR of all smears initially reported as nonpositive is a more effective and a fortiori a more cost effective quality control method in comparison with full rescreening of a 10% random sample.

Entities:  

Mesh:

Year:  2000        PMID: 11127751     DOI: 10.1159/000328615

Source DB:  PubMed          Journal:  Acta Cytol        ISSN: 0001-5547            Impact factor:   2.319


  2 in total

1.  The merits of new alternatives to the Papanicolaou test.

Authors:  E Ellison
Journal:  CMAJ       Date:  2001-09-18       Impact factor: 8.262

2.  Quality control for normal liquid-based cytology: rescreening, high-risk HPV targeted reviewing and/or high-risk HPV detection?

Authors:  Christophe E Depuydt; Marc Arbyn; Ina H Benoy; Johan Vandepitte; Annie J Vereecken; Johannes J Bogers
Journal:  J Cell Mol Med       Date:  2008-06-09       Impact factor: 5.310

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.